Diagnostyka FY25 Revenue Beats Forecasts 23.6%

Diagnostyka posted FY2025 revenue of PLN 2,410 mn, up 23.6% YoY, beating analyst estimate of PLN 2,404 mn and its own 20% guidance.
Adjusted EBITDA rose 15.3% to PLN 586.4 mn, missing consensus of PLN 616 mn, while margin fell to 24.3% from 26.1%.
Net profit declined 8.2% to PLN 251.6 mn, capex hit PLN 205 mn above guidance, and free cash flow reached PLN 541.2 mn with 92.6% conversion.
FY2026 outlook targets low‑to‑mid‑teens revenue growth, test‑volume low‑to‑mid single‑digit rise, price per test high single‑digit increase, and EBITDA margin near 24.3%.